ATE338767T1 - Dipeptidische wachstumshormonsekretionsförderern - Google Patents

Dipeptidische wachstumshormonsekretionsförderern

Info

Publication number
ATE338767T1
ATE338767T1 AT03716747T AT03716747T ATE338767T1 AT E338767 T1 ATE338767 T1 AT E338767T1 AT 03716747 T AT03716747 T AT 03716747T AT 03716747 T AT03716747 T AT 03716747T AT E338767 T1 ATE338767 T1 AT E338767T1
Authority
AT
Austria
Prior art keywords
growth hormone
dipeptidic
hormone secretion
secretion promoters
compounds
Prior art date
Application number
AT03716747T
Other languages
English (en)
Inventor
Britta Evers
Gerd Ruehter
Mark Joseph Tebbe
De La Nava Eva Maria Martin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0208116A external-priority patent/GB0208116D0/en
Priority claimed from GB0208117A external-priority patent/GB0208117D0/en
Priority claimed from GB0208120A external-priority patent/GB0208120D0/en
Priority claimed from GB0208119A external-priority patent/GB0208119D0/en
Priority claimed from GB0208118A external-priority patent/GB0208118D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE338767T1 publication Critical patent/ATE338767T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Golf Clubs (AREA)
  • Conductive Materials (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
AT03716747T 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern ATE338767T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US37127702P 2002-04-09 2002-04-09
US37127102P 2002-04-09 2002-04-09
US37127802P 2002-04-09 2002-04-09
US37127502P 2002-04-09 2002-04-09
US37127002P 2002-04-09 2002-04-09
GB0208116A GB0208116D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208117A GB0208117D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208120A GB0208120D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208119A GB0208119D0 (en) 2002-04-09 2002-04-09 Growth Hormone Secretagogues
GB0208118A GB0208118D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues

Publications (1)

Publication Number Publication Date
ATE338767T1 true ATE338767T1 (de) 2006-09-15

Family

ID=29255779

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03716747T ATE338767T1 (de) 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern
AT03714333T ATE332307T1 (de) 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03714333T ATE332307T1 (de) 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer

Country Status (7)

Country Link
US (1) US7396846B2 (de)
EP (2) EP1497317B1 (de)
AT (2) ATE338767T1 (de)
AU (2) AU2003218337A1 (de)
DE (2) DE60306636T2 (de)
ES (2) ES2266798T3 (de)
WO (2) WO2003087070A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040142A1 (en) 2003-10-24 2005-05-06 Aventis Pharmaceuticals Inc. Novel keto-oxadiazole derivatives as cathepsin inhibitors
EP1781311A4 (de) 2004-08-18 2010-02-17 Elixir Pharmaceuticals Inc Wachstumshormonsekretagoge
WO2006054166A1 (en) * 2004-11-18 2006-05-26 Pfizer Products Inc. Drugs and prodrugs useful for the treatment of energy balance in ruminants
WO2008028688A2 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
JP5268264B2 (ja) * 2007-02-07 2013-08-21 住友精化株式会社 アルカンジスルホニルハライドの製造方法
EP2471363A1 (de) * 2010-12-30 2012-07-04 Bayer CropScience AG Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711495A (en) * 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles
DE2359922A1 (de) * 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
US5242903A (en) * 1989-08-05 1993-09-07 Bayer Aktiengesellschaft Renin inhibitors
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5583130A (en) * 1992-09-25 1996-12-10 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
IL107836A (en) 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
WO1994013696A1 (en) * 1992-12-11 1994-06-23 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
US5536716A (en) * 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
DE4302957A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Imidazolyl-substituierte Phenylessigsäureprolinamide
US5344937A (en) * 1993-04-20 1994-09-06 Eli Lilly And Company Alkyl substituted nitroimidazole acetic acids
PL314003A1 (en) 1993-10-19 1996-08-05 Merck & Co Inc Combination of bisulphonates and substances enhancing secretion of growth hormone
US5494919A (en) * 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5492920A (en) * 1993-12-10 1996-02-20 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
JPH09505601A (ja) * 1993-11-24 1997-06-03 メルク エンド カンパニー インコーポレーテッド インドリル基含有化合物類および成長ホルモン放出を促進するためのそれらの使用
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
ZA9410186B (en) * 1994-01-10 1995-08-25 Santiago Abelardo Bojali Jaber Savourless antiamoebic antiprotozoan chemical product and procedure to obtain it
MX9605128A (es) * 1994-05-07 1997-08-30 Boehringer Ingelheim Kg Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
US5661161A (en) * 1994-09-29 1997-08-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US5559128A (en) * 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en) 1995-05-08 1996-11-14 Pfizer, Inc. Dipeptides which promote release of growth hormone
JP3133073B2 (ja) 1995-05-29 2001-02-05 ファイザー・インコーポレーテッド 成長ホルモンの放出を促進するジペプチド類
US5756528A (en) * 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1997006803A1 (en) 1995-08-21 1997-02-27 Eli Lilly And Company 2-acylaminopropanamides as growth hormone secretagogues
ZA966891B (en) 1995-08-21 1998-02-16 Lilly Co Eli 2-acylaminopropanamines as growth hormone secretagogues.
HUP9902095A3 (en) 1995-10-27 2001-05-28 Merck & Co Inc New process for the preparation of a growth hormone secretagogue
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU2931997A (en) 1996-05-07 1997-11-26 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
US5830855A (en) * 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents
WO1998016527A1 (en) 1996-10-15 1998-04-23 Fujisawa Pharmaceutical Co., Ltd. Benzoxepine derivatives which promote release of growth hormone
AU4993497A (en) 1996-10-25 1998-05-22 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
ZA987383B (en) 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
ZA987385B (en) 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
US6329342B1 (en) * 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
CA2341649A1 (en) 1998-09-02 2000-03-09 Merck & Co., Inc. Enhancement of return to independent living status with a growth hormone secretagogue
CO5160260A1 (es) * 1999-02-19 2002-05-30 Lilly Co Eli Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido
CA2419388A1 (en) * 2000-10-13 2002-04-25 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
CA2628025C (en) 2005-11-22 2011-10-25 Lg Electronics Inc. Device for limiting current of electric appliance

Also Published As

Publication number Publication date
WO2003087070A2 (en) 2003-10-23
WO2003087069A3 (en) 2004-03-25
DE60308166T2 (de) 2007-07-19
DE60306636T2 (de) 2007-07-05
DE60306636D1 (de) 2006-08-17
DE60308166D1 (de) 2006-10-19
AU2003218337A1 (en) 2003-10-27
AU2003218337A8 (en) 2003-10-27
WO2003087069A2 (en) 2003-10-23
EP1497317A2 (de) 2005-01-19
AU2003220441A1 (en) 2003-10-27
EP1497317B1 (de) 2006-09-06
ES2266798T3 (es) 2007-03-01
EP1497316B1 (de) 2006-07-05
WO2003087070A3 (en) 2003-12-31
US20050240001A1 (en) 2005-10-27
ATE332307T1 (de) 2006-07-15
ES2271557T3 (es) 2007-04-16
US7396846B2 (en) 2008-07-08
AU2003220441A8 (en) 2003-10-27
EP1497316A2 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
NO20031687L (no) Veksthormonsekretagoger
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
MY138258A (en) Growth hormone secretagogues
SE0202241D0 (sv) Novel Compounds
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
DE602005014632D1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
ATE338767T1 (de) Dipeptidische wachstumshormonsekretionsförderern
ATE372330T1 (de) N-sulfonylurea-apoptosis-förderer
TW200720225A (en) New one-step synthesis of useful disubstituted amines
DE50303586D1 (de) Methylthiophencarboxanilide
ATE428692T1 (de) 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen
DE602005007724D1 (de) Verfahren zur halbsynthese von deserpidin
ATE417055T1 (de) Steroid modifizierte solatriosen
DK1572615T3 (da) Fremgangsmåde til syntese af peptider indeholdende en 4-hydroxyprolin-substruktur
SG145574A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
ATE529115T1 (de) Kombinierte verwendung einer prostaglandin- verbindung und eines protonenpumpenhemmers zur behandlung von magen-darm-erkrankungen
ATE453623T1 (de) Synthese von dipeptidanaloga

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties